In The News

09.08.22

Reilly Quoted in Adweek on CCPA Data Exemption Effect on B2B Companies

Manatt Privacy and Data Security Partner Brandon Reilly was quoted in Adweek about the end of a California Consumer Privacy Act (CCPA) exemption that allowed companies to collect, use and share business-to-business data with little restriction under the state’s sweeping privacy law. With ...


09.07.22

Manatt Represents Francisco Partners in Majority Investment in Kobalt Music

A Manatt team led by Entertainment Leader Jordan Bromley and Partner Beau Stapleton advised Francisco Partners Management, a U.S.-headquartered global investment firm, with respect to its majority stake investment in Kobalt Music. We provided detailed analysis and insights into music, data privacy, ...


09.06.22

Manatt Successfully Wins PTAB Appeal for ECO FIRST Co., Ltd.

Manatt Intellectual Property Protection and Enforcement Partner Irah Donner and Patent Agent Shyh-Jye Wang successfully represented ECO FIRST Co., Ltd., in an appeal before the U.S. Patent Trial and Appeal Board in which all the U.S. Patent Office rejections were reversed.


09.04.22

Famili Quoted in POLITICO on the Federal Climate of the Booming Cannabis Industry

Leader of Manatt’s Cannabis and CBD practice Anita Famili spoke with POLITICO about how federal illegality is impacting cannabis businesses in states that have new recreational marijuana markets. In the article, Famili noted that marijuana companies are at a disadvantage when it comes to ...


09.02.22

Famili Named a 2022 Real Estate and Construction Law Trailblazer by The National Law Journal

Leader of Manatt’s Real Estate Transactions and Finance and Cannabis and CBD practices Anita Famili was named a Real Estate and Construction Law Trailblazer by The National Law Journal.  Famili was recognized for her work at the intersection of the cannabis and real estate ...


09.02.22

Sher Quoted in Law360 on State-Based Bans for Medication Abortion

Manatt Health Partner Rachel Sher was quoted in Law360 on states’ efforts to restrict access to mifepristone, the drug commonly utilized for medication abortion, after the U.S. Supreme Court’s decision in Dobbs v. Jackson Women's Health Organization. “These efforts are likely ...


09.01.22

Famili Named on Global Top 200 Cannabis Lawyers List

Manatt's Cannabis and CBD practice Leader Anita Famili was recognized on the 2022/2023 Global Top 200 Cannabis Lawyer list by the Cannabis Law Report.  Cannabis Law Report compiles its list of the leading cannabis lawyers through an annual survey of clients and lawyers in the cannabis ...


08.29.22

Manatt Obtains Asylum for LGBTQIA+ Nigerian Client

A Manatt team including Michelle Ceralvo, Barry Lee, Sirena Castillo and Alexandra McCown successfully represented a Nigerian asylum seeker—referred to as RL—who fled his home country following physical violence and abuse, harassment, and threats of imprisonment made against him ...


08.25.22

Manatt Represents Filmmaker David Kaufmann in ‘Weird NJ’ TV Series Sale to Sony Pictures Television

Manatt Entertainment Senior Counsel Larry Marks represented filmmaker David Kaufmann in the sale of screen rights for a new live-action horror-comedy series known as Weird NJ to Sony Pictures Television.


08.23.22

Spatz and Dworkowitz Quoted in InsuranceNewsNet on IRA Drug Pricing Webinar

Ian Spatz and Alex Dworkowitz were quoted in InsuranceNewsNet on Manatt’s August 23 webinar, “Preparing for Change: A Guide to the Inflation Reduction Act Drug Pricing Provisions.”